Clinical Trial Update: Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase I trial evaluating weekly topotecan in combination with sorafenib for relapsed small cell lung cancer has been completed. The study assessed safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Topotecan (topotecan)

Snippet

Sponsor: HealthPartners Institute | Conditions: Small Cell Carcinoma, Lung Cancer | Phase 1 | Status: COMPLETED